Definitive Contract 75D30122C13696
- Not listed
- This is a $47,916,380.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for serology testing services. The contract has a firm fixed price pricing type and a period of performance through March 5, 2022. The original solicitation was a pre-solicitation for laboratory testing of blood specimens to determine SARS-CoV-2 seroprevalence across the United States. The contract supports the CDC's public health initiatives...
- This is a $1,974,948.75 definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America Holdings (LabCorp), a global life sciences company. The contract is for medical laboratory testing and analysis services, including clinical diagnostics, reference laboratory testing, genetic testing, and specialized medical analyses. The contract does not have a set-aside designation, indicating LabCorp competed in an open market procurement....
- This is a firm fixed-price delivery order contract awarded to Laboratory Corporation of America (Labcorp) by the Centers for Disease Control and Prevention (CDC) on May 18, 2020. The contract is for "CLINIC LAB TESTS" and has a ceiling value of $90,043.40. The place of performance is in Burlington, North Carolina. This contract is not set aside for small businesses. Labcorp is a leading global life sciences company that provides comprehensive diagnostic testing and medical laboratory...
- This federal contract award was issued by the U.S. Secret Service, a civilian agency, to Laboratory Corporation of America (Labcorp) for the delivery of COVID-19 test kits. The contract, valued at $172,500.00, has an ultimate completion date of August 9, 2021 and is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type. The contract was awarded on August 7, 2020 and does not have a set-aside designation, indicating Labcorp was competitively selected. Labcorp is a leading...
- This is a delivery order awarded by the Department of the Army Medical Command to Laboratory Corporation of America (LabCorp), a leading global life sciences company, to provide COVID-19 clinical reference lab testing services. The firm fixed price contract, with a potential value of $349,092.19, has a completion date of February 28, 2021. LabCorp has extensive experience providing medical laboratory testing and analysis services to federal agencies, including the Department of Veterans Affairs,...
- This is a $240,000.00 firm fixed price delivery order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Laboratory Corporation of America (LabCorp) for clinical reference laboratory testing services. The contract was awarded on April 1, 2020 and has a completion date of September 30, 2020. LabCorp is a global life sciences company that provides diagnostic information services and has a history of delivering laboratory testing services under federal contracts. No...
- This is a $13,031,850.00 firm-fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (LabCorp) for genomic sequencing services. The contract has an ultimate completion date of May 14, 2022 and was awarded on December 26, 2021. LabCorp is a leading global life sciences company that provides diagnostic information services. They have extensive experience contracting with the federal government, including through their...
- This is a firm fixed price delivery order contract awarded by the Defense Health Agency (DHA) to Laboratory Corporation of America (LabCorp) for $103,965.00 to provide clinical reference laboratory testing services. The contract has a completion date of March 31, 2021. LabCorp, a global life sciences company, has previously provided medical laboratory testing and analysis services to various federal agencies through its GSA Federal Supply Schedule contract and other indefinite...
- This is a federal contract award to Laboratory Corporation of America, doing business as Labcorp, for Reference Laboratory Testing Services. The $100,000.00 firm-fixed-price delivery order is awarded by the Air Force Materiel Command, a defense agency. The contract has an ultimate completion date of March 31, 2023 and is not set aside for any socioeconomic category. Labcorp, the prime contractor, is a leading global life sciences company that provides comprehensive diagnostic testing services to...
- The U.S. Department of the Army Medical Command awarded a firm fixed price delivery order contract for $300,074.75 to Laboratory Corporation of America (LabCorp), a leading global life sciences company, for clinical reference laboratory testing services. This contract was not set aside and does not appear to be part of a larger contracting vehicle. LabCorp has been awarded numerous federal contracts to provide medical laboratory testing and analysis services in support of government healthcare...
This is a $91,693,500.00 firm-fixed-price definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp), a leading global life sciences company, for COVID-19 laboratory testing services. The contract has an ultimate completion date of April 22, 2025. Labcorp, a for-profit organization headquartered in Burlington, North Carolina, is the prime contractor and does not have any set-aside designation. The contract is not associated with a larger Indefinite Delivery Vehicle (IDV). Labcorp has extensive experience in providing specialized diagnostic services, including reference laboratory testing, genomic screening, and specimen transport, to various federal agencies such as the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Terminate for Convenience | $0 | 4/25/25 | |
| P00003 | Supplemental Agreement for work within scope | ($25m) | 8/28/23 | |
| P00002 | Exercise an Option | $26.0m | 5/25/23 | |
| P00001 | Exercise an Option | $39.0m | 1/19/23 | |
| Not listed | Not listed | $52.0m | 5/16/22 |